Aimmune Therapeutics Inc AIMT:NASDAQ

Last Price$27.97NASDAQ Previous Close - Last Trade as of 4:00PM ET 2/14/20

Today's Change0(0.00%)
Bid (Size)$27.92 (18)
Ask (Size)$28.15 (49)
Day Low / HighN/A - N/A
Volume1.0 M

Aimmune Therapeutics Begins Mid-Stage Trial of Egg Allergy Therapeutic

7:49AM ET 8/21/2019 MT Newswires
Aimmune Therapeutics (AIMT) said pre-market Wednesday that it has randomized its first patient in a phase 2 clinical trial of its investigational biological drug AR201 for the treatment of egg allergy.

Currently, there are no approved treatments for egg allergy, which disproportionately affects children and can be linked to severe hypersensitivity reactions, including life-threatening anaphylaxis, the company said.

Price: 20.66, Change: -0.74, Percent Change: -3.46